India, June 3 -- Shares of ReShape Lifesciences Inc. (RSLS) jumped over 33% on Tuesday morning after the company said its entire European and United Kingdom product portfolio has received Medical Device Regulation Certification.
RSLS is currently trading at $5.75, up $1.44 or 33.41%, on a large volume of 17.5 million, above average volume of 0.7 million, on the Nasdaq. The stock opened its trading at $5.70 after closing Monday at $4.31. The stock has traded between $4.03 and $414.70 in the past 52-week period.
ReShape Lifesciences announced that its Quality Management System (QMS) and entire commercial portfolio of medical devices sold in Europe and in the United Kingdom (UK) have been certified under the European Union (EU) Medical Devic...